Cargando…
The role of serotonin inhibition within the treatment of carcinoid syndrome
Carcinoid syndrome is the most frequent hormonal complication associated with neuroendocrine neoplasms. It was first reported in 1954, and the classical symptoms are diarrhoea, flushing and abdominal pain. It is caused by the secretion of several vasoactive substances, the most prominent being serot...
Autores principales: | George, Joel, Ramage, John, White, Benjamin, Srirajaskanthan, Rajaventhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305560/ https://www.ncbi.nlm.nih.gov/pubmed/37434648 http://dx.doi.org/10.1530/EO-22-0077 |
Ejemplares similares
-
Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome
por: Clement, Dominique, et al.
Publicado: (2020) -
A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
por: Basuroy, Ron, et al.
Publicado: (2012) -
Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2023) -
Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
por: Hofland, Johannes, et al.
Publicado: (2021) -
Nutritional and vitamin status in patients with neuroendocrine neoplasms
por: Clement, Dominique SVM, et al.
Publicado: (2019)